Evidence map›Paper›PMID 24142050›Full record

ArticleNature biotechnology2013

Engineering dynamic pathway regulation using stress-response promoters.

Robert H Dahl, Fuzhong Zhang, Jorge Alonso-Gutierrez, Edward Baidoo, Tanveer S Batth, Alyssa M Redding-Johanson, Christopher J Petzold, Aindrila Mukhopadhyay, Taek Soon Lee, Paul D Adams and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature biotechnology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 172 papers.

0numbers the graph read from it
0cells of the map it votes in
172citing papers in PubMed
19.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

172 citing papers in PubMed, 488 citations in OpenAlex.

  1. Metabolic engineering ofApplied and environmental microbiology · 2026
    Review
  2. Antibiotic-free high-yield (-)-α-bisabolol production inSynthetic and systems biotechnology · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Balancing Cell Growth and Product Synthesis for Efficient Microbial Cell Factories.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

112 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Robert H Dahl1] Joint BioEnergy Institute, Emeryville, California, USA. [2] Physical Biosciences Division, Lawrence Berkeley National Laboratory, Berkeley, California, USA. [3] Department of Chemical & Biomolecular Engineering, University of California, Berkeley, California, USA.
Fuzhong Zhang
Jorge Alonso-Gutierrez
Edward Baidoo
Tanveer S Batth
Alyssa M Redding-Johanson
Christopher J Petzold
Aindrila Mukhopadhyay
Taek Soon Lee
Paul D Adams
Jay D Keasling
Lawrence Berkeley National Laboratory · USJoint BioEnergy Institute · USUniversity of California, Berkeley · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heterologous pathways used in metabolic engineering may produce intermediates toxic to the cell. Dynamic control of pathway enzymes could prevent the accumulation of these metabolites, but such a strategy requires sensors, which are largely unknown, that can detect and respond to the metabolite. Here we applied whole-genome transcript arrays to identify promoters that respond to the accumulation of toxic intermediates, and then used these promoters to control accumulation of the intermediate and improve the final titers of a desired product. We apply this approach to regulate farnesyl pyrophosphate (FPP) production in the isoprenoid biosynthetic pathway in Escherichia coli. This strategy improved production of amorphadiene, the final product, by twofold over that from inducible or constitutive promoters, eliminated the need for expensive inducers, reduced acetate accumulation and improved growth. We extended this approach to another toxic intermediate to demonstrate the broad utility of identifying novel sensor-regulator systems for dynamic regulation.

Indexed as

Cluster AnalysisEscherichia coliEscherichia coli ProteinsGene Expression ProfilingMetabolic EngineeringMetabolic Networks and PathwaysPolycyclic SesquiterpenesPolyisoprenyl PhosphatesSesquiterpenesStress, PhysiologicalSystems Biologyamorpha-4,11-dieneEscherichia coli Proteinsfarnesyl pyrophosphatePolycyclic SesquiterpenesPolyisoprenyl PhosphatesSesquiterpenes

Identifiers

PMID24142050
OpenAlexW2092122738

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.